CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. is a joint venture invested and established by CSPC Pharmaceutical Group Co., Ltd. in the Mainland. It is a production base specialized in the manufacturing of antibiotic raw materials and preparations in China as well as a major generic drug supplier in China. The market share of its amoxicillin dispersible tablets and amoxicillin capsules ranks first in the industry.

The main products of the company include: APIs including penicillin G potassium salt, benzylpenicillin potassium, benzylpenicillin sodium, amoxicillin, ampicillin, ampicillin sodium, cefazolin sodium, meropenem, biapenem, ertapenem; preparations including benzylpenicillin sodium for injection, ampicillin sodium for injection, cefazolin sodium for injection, cefradine for injection, ceftriaxone sodium for injection, cefotaxime sodium for injection, cefoperazone sodium for injection, amoxicillin capsules, amoxicillin dispersible tablets, etc. Among them, the first inspections of cephalosporin powder for injection, tablets and capsules have all passed the US FDA certification with "zero defects"; the annual production of powder for injection, capsules and tablets is 1.2 billion, 4.4 billion and 800 million, respectively. There are four major dosage forms: powder for injection, capsules, tablets, and granules, and more than 150 specifications for antibiotics. All products have passed GMP certification and met the latest national standards of China.

The company insists on scientific and technological innovation to promote business development, and continuously strengthens its R&D investments and capabilities. At present, there are more than 200 sets of lab instruments in the research institute, mainly used for new product process development, technical route determination, pilot study of synthesis, and production  transformation design. Two of the projects are listed as provincial-level scientific and technological innovation projects. The project of “Construction of enzyme engineering technology platform and its application in the pharmaceutical industry" was awarded with Scientific and Technological Achievement Award Appraisal of Hebei Province and won the third prize of Scientific and Technological Progress Award of Hebei Province and the first prize of Science and Technology Award of Shijiazhuang City. At present, the research institute  serves as the Antibiotic Engineering and Technology Research Center of Hebei Province, and is also a teaching practice base operated jointly with Hebei University.

The company maintains, develops and expands its market on the basis of quality and reputation. It always adheres to the business philosophy of "Providing the Best Quality to Our Valued Customers", through strict control of product qualities and providing professional technical support to the customers. Our main products have passed the US FDA certification and the European COS certification, and the high standard of the company’s product quality and professional services have received unanimous praise from our customers.  The company  has also earned high regards in successive external audits. At present, the company's products have not only distributed to all provinces (municipalities) in China, but also exported to more than 30 countries and regions, including Europe and the United States.